Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FXKHB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,914
Award facts
- Contract value 100% obligated
- $20,914.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,914.14 to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml pen injectors. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a specific pharmaceutical procurement to support federal medical supply needs, likely for military or veteran healthcare systems managed through the Defense Logistics Agency's medical supply chain.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare programs globally. Dupixent is a biologic treatment commonly used for conditions such as atopic dermatitis, asthma, and eosinophilic esophagitis, indicating this delivery supports the provision of specialty pharmaceutical products to federal healthcare beneficiaries. The non-set-aside status reflects AmerisourceBergen's competitive capability in federal medical procurement.
Quick answers
Who was awarded contract SPE2DB25FXKHB?
SPE2DB25FXKHB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FXKHB worth?
The government has obligated $20,914 on SPE2DB25FXKHB.
Is contract SPE2DB25FXKHB an order under another contract?
Yes. SPE2DB25FXKHB is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXKHB competed?
The extent of competition for SPE2DB25FXKHB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award